Skip to main content

Peer Review reports

From: Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

Original Submission
17 Dec 2021 Submitted Original manuscript
14 Jan 2022 Reviewed Reviewer Report - Irene Mattavelli
16 Jan 2022 Reviewed Reviewer Report
21 Feb 2022 Author responded Author comments - Giovanni Battista Bolla
Resubmission - Version 2
21 Feb 2022 Submitted Manuscript version 2
24 Feb 2022 Author responded Author comments - Giovanni Battista Bolla
Resubmission - Version 3
24 Feb 2022 Submitted Manuscript version 3
28 Feb 2022 Author responded Author comments - Giovanni Battista Bolla
Resubmission - Version 4
28 Feb 2022 Submitted Manuscript version 4
12 Mar 2022 Reviewed Reviewer Report - Irene Mattavelli
18 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
30 Mar 2022 Editorially accepted
13 May 2022 Article published 10.1186/s12872-022-02647-0

You can find further information about peer review here.

Back to article page